Hill Matthew C's Form 4 filing
PDS Biotechnology Corp (PDSB) · filed Dec 14, 2021
- Accession no.
- 0001140361-21-041473
- Filed
- Dec 14, 2021
- Trade date
- Dec 13, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market purchases total $27.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hill Matthew CCIK 0001278675 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 13, 2021 | Common Stock | PPurchaseAcquired | +2,500 | $9.00 | +$22,500 | 3,475 | Direct | |
| Dec 13, 2021 | Common Stock | PPurchaseAcquired | +400 | $8.90 | +$3,560 | 3,875 | Direct | |
| Dec 13, 2021 | Common Stock | PPurchaseAcquired | +100 | $9.00 | +$900 | 3,975 | Indirect | |
| Dec 13, 2021 | Common Stock | PPurchaseAcquired | +100 | $9.00 | +$900 | 4,075 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.